SEVERE DYSPHAGIA "POOR PROGNOSTIC MARKER" IN IDIOPATHIC INFLAMMATORY MYOPATHIES

被引：0
|
作者：
Costi, A. G. [1 ]
Garcia, L. [1 ]
Pena, C. [1 ]
Testi, A. [1 ]
Sansinanea, P. [1 ]
Aguila, R. [1 ]
Pera, M. [1 ]
Velloso, S. [1 ]
Savy, F. [1 ]
Garcia, M. [1 ]
机构：
[1] HIGA San Martin, Reumatol, La Plata, Buenos Aires, Argentina
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5367
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0725
引用
收藏
页码：1501 / 1502
页数：2
相关论文
共 50 条
  • [1] SEVERE DYSPHAGIA: "A POOR PROGNOSTIC MARKER" IN IDIOPATHIC INFLAMMATORY MYOPATHIES
    Carolina Costi, Ana
    Garcia, Lucila
    Elizabeth Pena, Claudia
    Aguila, Rodrigo
    Savy, Florencia
    Velloso, Sofia
    Nagua, Viviana
    Testi, Adriana
    Sansinanea, Pierina
    Argentina Garcia, Mercedes
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S22 - S23
  • [2] DYSPHAGIA: POOR PROGNOSIS IN IDIOPATHIC INFLAMMATORY MYOPATHIES
    Carolina Costi, Ana
    Pena, Claudia
    Testi, Adriana
    Sansinanea, Pierina
    Garcia, Mercedes
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1558 - 1558
  • [3] Re-evaluation of the prognostic significance of oropharyngeal dysphagia in idiopathic inflammatory myopathies
    Kim, J. G.
    Park, Y.
    Lee, J.
    Ju, J. H.
    Kim, W-U
    Park, S-H
    Kwok, S-K
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (05) : 402 - 410
  • [4] Can tissue transglutaminase be a marker of idiopathic inflammatory myopathies?
    Gendek, EG
    Kedziora, J
    Gendek-Kubiak, H
    IMMUNOLOGY LETTERS, 2005, 97 (02) : 245 - 249
  • [5] IDIOPATHIC INFLAMMATORY MYOPATHIES: CLINICAL CHARACTERISTICS, SURVIVIAL AND POOR PROGNOSTIC FACTORS OF 110 PATIENTS FROM TURKEY
    Oguz, E.
    Erdugan, M.
    Esen, B. A.
    Gul, A.
    Ocal, L.
    Inanc, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 750 - 750
  • [6] IDIOPATHIC INFLAMMATORY MYOPATHIES: CLINICAL CHARACTERISTICS, SURVIVAL AND POOR PROGNOSTIC FACTORS OF 110 PATIENTS FROM TURKEY
    Oguz, E.
    Erdugan, M.
    Esen, B. Artim
    Gul, A.
    Ocal, L.
    Inanc, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S53 - S53
  • [7] Myostatin in inflammatory idiopathic myopathies: a marker of activity and muscle recovery?
    Mahoudeau, A.
    Maillard, S.
    Anquetil, C.
    Tawara, N.
    Amelin, D.
    Allenbach, Y.
    Benveniste, O.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S137 - S138
  • [8] EFFICACY OF INTRAVENOUS IMMUNOGLOBULIN THERAPY IN REFRACTORY DYSPHAGIA IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
    Giannini, M.
    Fiorella, M. L.
    D'Abbicco, D.
    Amati, A.
    Lia, A.
    Girolamo, F.
    Cacciapaglia, F.
    Iannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 639 - 639
  • [9] Outcome of idiopathic inflammatory myopathies:: complications, survival and prognostic factors
    Miró, O
    Laguno, M
    Alonso, JR
    Casademont, J
    Herrero, C
    Selva, A
    Urbano-Márquez, A
    Grau, JM
    MEDICINA CLINICA, 1999, 112 (14): : 521 - 526
  • [10] Idiopathic inflammatory myopathies
    Vincze, Melinda
    Danko, Katalin
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2012, 26 (01): : 25 - 45
12345